Tackling TB Together: Our shared fight for a TB-free future
Want to be part of the global effort to end TB?
Join our shared fight for a TB-free future at the Global TB Summit 2024.
Can’t attend live? No worries. Register now, and we'll send you the recording after the event.
Program: All talks at a glance
| Block 1: TB and the current landscape: Time in CET
| |
| 14:00–14:10 | Welcome and introduction Chair, Prof. Onn Min Kon, Consultant Respiratory Physician, Imperial College London, England |
| 14:10–14:40 | Epidemiology of TB in the WHO European region 2024 Dr. Askar Yedilbayev, WHO-EU, Regional Adviser, TB and DR-TB, Division of Communicable Diseases, Environment and Health |
| 14:40–15:10 | TB and vaccines Prof. Hazel M. Dockrell, Professor of Immunology, London School of Hygiene & Tropical Medicine, England |
| 15:10–15:30 | Break |
| Block 2: People within the current TB landscape: Time in CET | |
| 15:30–16:00 | Facilitating healthy migration: IOM experience in integrating TB/LTB screening and treatment in the regular migration pathways Dr. Alexander Klosovsky, Senior Migration Health Advisor, Global Health Security, International Organization for Migration, Switzerland |
| 16:00–16:30 | Person-centered strategies to address the socioeconomic determinants and consequences of tuberculosis Dr. Tom Wingfield, WHO Collaborating Centre for Social Medicine and Tuberculosis, Department of Global Public Health Sciences, Karolinska Institute, Sweden |
| 16:30–16:45 | Break |
| Block 3: Advances in TB: Time in CET | |
| 16:45–17:15 | Novel diagnostics Dr. Morten Ruhwald, Director Tuberculosis, FIND, Switzerland |
| 17:15–17:45 | New shorter regimens for rifampicin-resistant tuberculosis Dr. Lorenzo Guglielmetti, Infectious Diseases Consultant and Epidemiologist, National Reference Center for Mycobacteria in Paris, France |
| 17:45–18:00 | Conclusion and close of Day 1 |
| Block 1: TB update from APEC: Time in CET | |
| 9:00–9:10 | Welcome and introduction |
| 9:10–9:40 | Mycobacterium tuberculosis transmission analysis by whole genome sequencing Prof. Satoshi Mitarai M.D, Professor of Basic Mycobacteriosis, Graduate School of Biomedical Sciences, Nagasaki University and Director (Professor) of The Research Institute of Tuberculosis, Japan |
| 9:40–10:10 | MDR-TB treatment in China Prof. Wei Sha, Chief Physician and Professor, Director of the Clinical Medical Center for Infectious Diseases (Tuberculosis Department), Shanghai Pulmonary Hospital, China |
| 10:10–10:40 | Toward precision TB preventive therapy Prof. Jann-Yuan Wang, Division of Chest, Department of Internal Medicine, National Taiwan University Hospital and President, Taiwan Society of Tuberculosis and Lung Disease |
| 10:40–11:00 | Break |
| 11:00–11:30 | Community-driven efforts of the COMMIT project to combat TB in Cambodia Dr. Sovanvorleak Tep, Research Officer, KHANA, Cambodia, |
| 11:30–12:00 | Updating the Singapore TB clinical guidelines: Screening for TB infection Prof. Hsu Li Yang, National University of Singapore, Vice Dean, Singapore |
| 12:00–12:30 | Implementation of IGRA for TB infection testing in India: Findings and learnings Dr. Shamim Mannan, Associate Director and TB Lead, Clinton Health Access Initiative, India |
| 12:30–12:45 | Conclusion and close of Day 2, Block 1 |
| Block 2: TB update from the Americas: Time in CET | |
| 14:00–14:10 | Welcome and introduction Chair, Prof. Onn Min Kon, Consultant Respiratory Physician, Imperial College, England |
| 14:10–14:40 | TB in LATAM Prof. Carlton A Evans FRCP PhD MBE, Professor of Global Health, Imperial College London, UK and Head of Innovation for Health and Development, Asociacion Benefica PRISMA, Peru |
| 14:40–15:10 | Modelo de Atención Integral para pacientes con Tuberculosis (Integral care model for patients with tuberculosis) Dr. Isaías Orozco Andrade, Head of the Tuberculosis Clinic of the Children's Hospital of Specialty of Ciudad Juarez and Medical Coordinator of the Binational Tuberculosis Project JUNTOS in Ciudad Juárez, Chihuahua, México. |
| 15:10–15:40 | TB infection detection and treatment in low-resource scenarios Dr. Rosa Herrera, Director of the School of Medicine, Autonomous University of Durango, Mexicali Campus, México |
| 15:40–16:00 | Break |
| 16:00–16:30 | Detection and prevention of tuberculosis among new arrivals in Chicago Dr. Kathy Ritger, MD, MPH, Medical Director, Tuberculosis Program Chicago Department of Public Health, Chicago, USA |
| 16:30–17:00 | Healthcare workers: TB update Dr. Melanie Swift, Interim Chair, Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, Minnesota |
| 17:00–17:15 | Conclusion and close of Day 2, Block 2 |
| Block: Risk groups special: Time in CET | |
| 9:00–9:10 | Welcome and introduction Chair, Prof. Onn Min Kon, Consultant Respiratory Physician, Imperial College London, England |
| Spotlight: TB and pediatrics | |
| 9:10–9:40 | Management of children exposed to multidrug-resistant tuberculosis Prof. James Seddon, Professor of Global Child Health at Imperial College, Consultant in Pediatric Infectious Diseases, St. Mary's Hospital, England |
| 9:40–10:10 | TB treatment shortening in children: Results of the SHINE trial Dr. Elizabeth Whittaker, Senior Clinical Lecturer in paediatric infectious diseases and immunology, Imperial College, England |
| 10:10–10:30 | Break |
| Spotlight: Migrant health | |
| 10:30–11:00 | Defining a migrant-inclusive tuberculosis research agenda to end TB Prof. Alberto Matteelli, Professor of Infectious and Tropical Diseases at the University of Brescia, Brescia, Italy |
| Spotlight: Diabetes | |
| 11:00–11:30 | TB and diabetes Prof. Manish Pareek, Clinical Professor in Infectious Disease, University of Leicester, England |
| Spotlight: HIV | |
| 11:30–12:00 | TB and HIV Prof. Anton Pozniak, Consultant physician in HIV Medicine, Chelsea and Westminster Hospital, England |
| 12:00–12:10 | Conclusion and close of Day 3 |
| Hybrid block in London: Time in CET (BST in parentheses) | |
| 10:15–10:30 (9:15–9:30) | Welcome and introduction Chair, Prof. Onn Min Kon, Consultant Respiratory Physician, Imperial College, England |
| 10:30–11:00 (9:30–10:00) | Keynote: How to get governments to act on TB? Nick Herbert (Lord Herbert of South Downs CBE PC), founder and Global Chair of the Global TB Caucus, Member of the House of Lords in the United Kingdom Parliament |
| 11:00–11:30 (10:00–10:30) | TB services in England: A GIRFT review Dr. Martin Allen, Consultant Physician, GIRFT National Clinical Lead for Respiratory Medicine and National Specialty Adviser for Physiological Science, NHS, England |
| 11:30–12:05 (10:30–11:05) | TB action plan for England Dr. Esther Robinson, Head of the TB Unit at UKHSA, England Steve Hindle, Infectious Diseases Programme Manager, Prevention and Long Term Conditions Team, Medical Directorate, NHS England |
| 12:05–12:35 (11:05–11:35) | Break |
| 12:30–13:00 (11:30–12:00) | TB and silicosis in miners: Challenges and opportunities Dr. Patrick Howlett, MRC Clinical Research Fellow, Imperial College London, England |
| 13:00–13:30 (12:00–12:30) | Sub-clinical TB Dr. Hanif Esmail, Clinical Senior Lecturer, Institute of Clinical Trials & Methodology, University College London, England |
| 13:30–14:00 (12:30–13:00) | Down and out in London: How the hunger of poverty feeds tuberculosis What is the lived experience of a person with tuberculosis in London in 2024? Dr. Padmasayee Papineni, Consultant in Infectious Diseases at London North West University NHS Trust, England Ahmed Yassin, Outreach TB Worker, Ealing TB service, NHS, England |
| 14:00–15:00 (13:00–14:00) | Lunch |
| 15:00–15:30 (14:00–14:30) | Role of whole genome sequence in surveillance and diagnostics Dr. Andrea Cabibbe, San Raffaele Scientific Institute, Italy |
| 15:30–16:00 (14:30–15:00) | Pleural TB Dr. Jane Shaw, Pulmonologist and Clinical Researcher, Stellenbosch University, South Africa |
| 16:00–16:30 (15:00–15:30) | Break |
| 16:30–17:30 (15.30–16:30) | Clinical TB cases TB case 1: Pulmonary tuberculosis and severe respiratory failure Dr. Matthew Burman, Respiratory Consultant at Homerton Healthcare NHS Foundation Trust, England TB case 2: Treating the untreatable: Treatment and ethical issues in functionally pan-resistant TB Dr. Patrick Lillie, Consultant, Hull and East Yorkshire Hospitals NHS Trust, England TB case 3Dr. David Connell, Honorary Senior Lecturer, University of Dundee, England |
| 17:30–17:45 (16:30–16:45) | Conclusion and close of the summit Chair, Prof. Onn Min Kon, Consultant Respiratory Physician, Imperial College London, England |
TB is one of the world's most deadly infectious diseases. Here’s your chance to fight TB.
Global TB Summit 2024: What to expect?
The Global TB Summit brings together everyone involved in the fight against TB — doctors, nurses, advocates, survivors and patients. Together, we can make a real difference.
Join over 35 TB experts and thousands of attendees from all over the world and be part of the global effort to end TB.
- When: October 8–11, 2024
- Where: Online (October 8–10), hybrid at the Royal College of Physicians (RCP) in London (October 11)
- How much: Free to register and attend
- What: CPD- and CME-accredited educational event
Global TB Summit 2024: Who should attend?
- TB fighters: Learn about the latest research and innovations
- Healthcare professionals: Gain clinical insights and best practices
- Advocates: Network and share your passion for ending TB
- Survivors and patients: Your experiences and voices are vital to our mission
Global TB Summit 2024: Highlights
The summit will bring together over 35 top TB experts to share insights and strategies, complemented by inspiring personal stories from patients and nurses on the frontlines and community initiatives to motivate and educate attendees. Here are some of the expert talks you can look forward to:
- Global TB updates
- Regional updates from Asia Pacific, Europe and the Americas
- Advances in TB vaccines
- TB amidst global conflicts
- TB infection control
- Novel diagnostics and treatments
- Special focus on risk groups (children, migrants, diabetes patients, those with HIV)
Are you prepared to contribute to a TB-free future?
Join our shared fight for a TB-free future at the Global TB Summit 2024.
Can’t attend live? No worries. Register now, and we'll send you the recording after the event.